Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASE1 | P07998 | 1/20 | 0.55 |
| ▸ | TK1 | P04183 | 5/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19407973 | 0.88 | RNASE1 (0.71) | RNASE1TK1 | |
| SCHEMBL3337696 | 0.88 | RNASE1 (0.71) | RNASE1TK1 | |
| SCHEMBL16417829 | 0.84 | RNASE1 (0.49) | RNASE1TK1ABCG2ABCB1 | |
| SCHEMBL17930897 | 0.84 | RNASE1 (0.49) | RNASE1TK1ABCG2ABCB1 | |
| SCHEMBL9397478 | 0.84 | TK1 (0.65) | RNASE1TK1ABCG2 | |
| SCHEMBL21078821 | 0.81 | TOP2A (0.57) | RNASE1TK1 | |
| SCHEMBL774263 | 0.80 | RNASE1 (0.68) | RNASE1TK1 | |
| SCHEMBL767324 | 0.80 | RNASE1 (0.68) | RNASE1TK1 | |
| SCHEMBL14681227 | 0.80 | RNASE1 (0.68) | RNASE1TK1 | |
| SCHEMBL16287348 | 0.80 | RNASE1 (0.68) | RNASE1TK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212209-A1 | COMPOSITIONS AND METHODS FOR LIQUID PHASE OLIGONUCLEOTIDE SYNTHESIS | HONGENE BIOTECH CORPORATION | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212209-A1 | COMPOSITIONS AND METHODS FOR LIQUID PHASE OLIGONUCLEOTIDE SYNTHESIS | POLR2H, POLR2E, POLI | RNASE1 333/4885TK1 325/4885ABCG2 3490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.